HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity

被引:232
作者
Fedele, Monica
Visone, Rosa
De Martino, Ivana
Troncone, Giancarlo
Palmieri, Dario
Battista, Sabrina
Ciarmiello, Andrea
Pallante, Pierlorenzo
Arra, Claudio
Melillo, Rosa Marina
Helin, Kristian
Croce, Carlo Maria
Fusco, Alfredo [1 ]
机构
[1] Univ Naples Federico II, CNR, Ist Endocrinol & Oncol Sperimentale, I-80131 Naples, Italy
[2] Univ Naples Federico II, Dipartimento Biol & Patol Cellulare & Mol, I-80131 Naples, Italy
[3] Ohio State Univ, Ctr Comprehens Canc, Div Human Canc Genet, Columbus, OH 43210 USA
[4] Univ Naples Federico II, Dipartimento Anat Patol, I-80131 Naples, Italy
[5] Ist Tumori Napoli, Fdn G Pascale, I-80131 Naples, Italy
[6] Biotech Res & Innovat Ctr, DK-2100 Copenhagen, Denmark
[7] European Inst Oncol, Dept Expt Oncol, I-20141 Milan, Italy
[8] CEINGE, NOGEC, Naples Oncogenom Ctr, Naples, Italy
关键词
D O I
10.1016/j.ccr.2006.04.024
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
HMGA2 gene amplification and overexpression in human prolactinomas and the development of pituitary adenomas in HMGA2 transgenic mice showed that HMGA2 plays a crucial role in pituitary tumorigenesis. We have explored the pRB/ E2F1 pathway to investigate the mechanism by which HMGA2 acts. Here we show that HMGA2 interacts with pRB and induces E2F1 activity in mouse pituitary adenomas by displacing HDAC1 from the pRB/E2F1 complex -a process that results in E2F1 acetylation. We found that loss of E2F1 function (obtained by mating HMGA2 and E2F1(-/-) mice) suppressed pituitary tumorigenesis in HMGA2 mice. Thus, HMGA2-mediated E2F1 activation is a crucial event in the onset of these tumors in transgenic mice and probably also in human prolactinomas.
引用
收藏
页码:459 / 471
页数:13
相关论文
共 27 条
[1]   The pathogenesis of pituitary tumours [J].
Asa, SL ;
Ezzat, S .
NATURE REVIEWS CANCER, 2002, 2 (11) :836-849
[2]   Onset of natural killer cell lymphomas in transgenic mice carrying a truncated HMGI-C gene by the chronic stimulation of the IL-2 and IL-15 pathway [J].
Baldassarre, G ;
Fedele, M ;
Battista, S ;
Vecchione, A ;
Klein-Szanto, AJP ;
Santoro, M ;
Waldmann, TA ;
Azimi, N ;
Croce, CM ;
Fusco, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (14) :7970-7975
[3]   High-mobility-group A1 (HMGA1) proteins down-regulate the expression of the recombination activating gene 2 (RAG2) [J].
Battista, S ;
Fedele, M ;
Hoyos, JM ;
Pentimalli, F ;
Pierantoni, GM ;
Visone, R ;
De Martino, I ;
Croce, CM ;
Fusco, A .
BIOCHEMICAL JOURNAL, 2005, 389 :91-97
[4]  
Battista S, 1999, CANCER RES, V59, P4793
[5]   EXPRESSION OF A RETINOBLASTOMA TRANSGENE RESULTS IN DWARF MICE [J].
BIGNON, YJ ;
CHEN, YM ;
CHANG, CY ;
RILEY, DJ ;
WINDLE, JJ ;
MELLON, PL ;
LEE, WH .
GENES & DEVELOPMENT, 1993, 7 (09) :1654-1662
[6]   THE RETINOBLASTOMA GENE IN HUMAN PITUITARY-TUMORS [J].
CRYNS, VL ;
ALEXANDER, JM ;
KLIBANSKI, A ;
ARNOLD, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 77 (03) :644-646
[7]   Truncated and chimeric HMGI-C genes induce neoplastic transformation of NIH3T3 murine fibroblasts [J].
Fedele, M ;
Berlingieri, MT ;
Scala, S ;
Chiariotti, L ;
Viglietto, G ;
Rippel, V ;
Bullerdiek, J ;
Santoro, M ;
Fusco, A .
ONCOGENE, 1998, 17 (04) :413-418
[8]   Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomas [J].
Fedele, M ;
Battista, S ;
Kenyon, L ;
Baldassarre, G ;
Fidanza, V ;
Klein-Szanto, AJP ;
Parlow, AF ;
Visone, R ;
Pierantoni, GM ;
Outwater, E ;
Santoro, M ;
Croce, CM ;
Fusco, A .
ONCOGENE, 2002, 21 (20) :3190-3198
[9]   Role of the high mobility group A proteins in human lipomas [J].
Fedele, M ;
Battista, S ;
Manfioletti, G ;
Croce, CM ;
Giancotti, V ;
Fusco, A .
CARCINOGENESIS, 2001, 22 (10) :1583-1591
[10]   E2F-1 functions in mice to promote apoptosis and suppress proliferation [J].
Field, SJ ;
Tsai, FY ;
Kuo, F ;
Zubiaga, AM ;
Kaelin, WG ;
Livingston, DM ;
Orkin, SH ;
Greenberg, ME .
CELL, 1996, 85 (04) :549-561